Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: BHC

Bausch Health Companies Inc.

Healthcare | Drug Manufacturers - Specialty & Generic

No licensed closing price on file for BHC. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-2.96

Bausch Health Companies Inc. (NYSE: BHC) is a specialty and generic drug manufacturer. Figures from SEC EDGAR; updated 2026-10-20 03:54 UTC.

What Bausch Health Companies Inc. does

Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company that develops, manufactures and markets products in gastroenterology, hepatology, neurology, dermatology, and eye health through five reportable segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company operates in approximately 90 countries and offers branded, generic, and branded generic pharmaceuticals, over-the-counter products, and medical devices including contact lenses, intraocular lenses, and ophthalmic surgical equipment.

Summarized from Bausch Health Companies Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-2.96

Revenue, margins & earnings

FY2021: net loss $948M on revenue $8.43B$8.43BFY2021FY2022: net loss $225M on revenue $8.12B$8.12BFY2022FY2023: net loss $592M on revenue $8.76B$8.76BFY2023FY2024: net loss $46M on revenue $9.62B$9.62BFY2024FY2025 Net income: $157MFY2025 Taxes & interest: $1.66BFY2025 Operating costs: $8.45B$10.3BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-02
  • 2026-10-02DirectorAward5,789$33.7K
  • 2026-10-02DirectorAward1,179$6.9K
  • 2026-10-02DirectorAward10,720$62.5K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Bausch Health Companies Inc. do?

Bausch Health Companies Inc. is a specialty and generic drug manufacturer, listed on NYSE as BHC.

When did BHC last file with the SEC?

Bausch Health Companies Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-01. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 03:54 UTC. This page is also available as JSON at /api/data?ticker=BHC and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BHC and 5,000+ tickers.

Create a free account — keep BHC
For your agent
GET /api/data?ticker=BHC

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt